Fig. 2
From: Diagnostic role of circulating extracellular matrix-related proteins in non-small cell lung cancer
Levels of COL10A1 and SPARC are significantly higher in plasma of lung cancer patients compared to healthy heavy controls. a and c Box plots of COL10A1 and COL11A1 levels measured in plasma of 57 lung cancer patients (TU) and 57 healthy donors (CTR). b Boxplots of SPARC levels measured in plasma of 90 lung cancer patients (TU) and 90 controls (CTR), p = Wilcoxon test p-value